Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02298322 · ClinicalTrials.gov registry record · NA
Subcutaneous Fat Reduction in the Submental Area
A NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT02298322: Completed NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
NCT02298322 is a NA study of Body Fat Disorder that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 60 participants, above the 28-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (114% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02298322, a NA study of Body Fat Disorder, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area using Cryolipolysis. Healthy adult men and women with submental skin fold thickness \> 1cm who desire reduction of submental fat.
Primary Outcome
Safety of the Zeltiq CoolSculpting device will be assessed by measuring the incidence of device- and/or procedure-related adverse events. Adverse event reports are collected from the time of enrollment through the 12 week follow-up visit.
Conditions Studied
Interventions
- DEVICE CoolSculpting System
Study Locations (3)
California
- Laser & Skin Surgery Center of Northern California - Sacramento
Minnesota
- Zel Skin & Laser Specialists - Edina
Texas
- EpiCentre Skin and Laser Center - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-11-11 |
| Est. Completion | 2015-08-02 |
| Phase | NA |
What the finished NCT02298322 record still lists
NCT02298322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 28-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (114% higher).
The record links to 1 condition, with Body Fat Disorder appearing as the primary indexed condition, and to 1 intervention - of which CoolSculpting System is the first listed.
NCT02298322 reports a single indexed study location in California, Minnesota, Texas.
Frequently Asked Questions
What is clinical trial NCT02298322 about?
NCT02298322 is a clinical study titled "Subcutaneous Fat Reduction in the Submental Area". Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area using Cryolipolysis. Healthy adult men and women with submental skin fold thickness \> 1cm who desire reduction of submental fat.
What is the current status of trial NCT02298322?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-11-11. Estimated completion is 2015-08-02.
What conditions does trial NCT02298322 study?
This clinical trial studies the following conditions: Body Fat Disorder.
What interventions are being tested in trial NCT02298322?
The interventions under investigation include: CoolSculpting System (DEVICE).
Who is sponsoring clinical trial NCT02298322?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02298322 being conducted?
This trial has 3 study locations across California, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Fat Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI